Latest News

In March 2026, Erasca, Inc. reported a full-year 2025 net loss of US$124.55 million, with basic loss per share from continuing operations of US$0.44, both improving versus the prior year. Earlier that month, Erasca exercised its option to expand its license with Joyo Pharmatech, securing exclusive global rights to the potential pan-RAS molecular glue ERAS-0015 and enabling a single worldwide development and commercialization plan. With Erasca now holding worldwide rights to ERAS-0015, we’ll...

In recent months, AST SpaceMobile has secured a US$30 million U.S. Space Development Agency contract, expanded commercial partnerships such as a Telus deal that includes an equity stake, advanced its BlueBird 6 and 7 satellite deployments, and reported its first year of revenue driven by multiple U.S. government contracts. These developments, alongside a US$1.20 billion contracted backlog, partnerships with more than 50 mobile network operators and increasing institutional ownership from...

CytomX Therapeutics recently reported full-year 2025 results showing sales of US$76.2 million and a net loss of US$17.37 million, and has just raised roughly US$250.00 million through a follow-on offering of common stock and pre-funded warrants at about US$5.30 per security. At the same time, the company released encouraging Phase 1 data for its EpCAM-targeted ADC Varseta-M in heavily pretreated metastatic colorectal cancer, with a high disease control rate and a safety profile that appears...

Elastic N.V. (NYSE:ESTC) is scheduled to participate in the HIMSS 2026 Global Health Conference & Exhibition. The event is one of the larger gatherings focused on healthcare IT and digital health solutions. Elastic's presence highlights its efforts to engage with healthcare providers, payers, and technology partners. For investors watching NYSE:ESTC, this appearance puts Elastic in front of a healthcare audience that depends heavily on search, observability, and data security tools...

Five Below (FIVE) has wrapped up FY 2026 with fourth quarter revenue of US$1.7b and basic EPS of US$4.32, supported by same store sales growth of 15.4%. Over the past few quarters, the company has seen revenue move from US$843.7m in Q3 2025 to US$1.0b in Q3 2026 and US$1.7b in Q4 2026, while quarterly basic EPS shifted from US$0.03 in Q3 2025 to US$0.66 in Q3 2026 and US$4.32 in the latest quarter, with trailing twelve month EPS at US$6.51. With trailing twelve month same store sales growth...

Lithium Americas announced material progress with the U.S. Department of Energy on its Thacker Pass project in Nevada, reducing key development risks. The company paired this update with news of a CA$250 million follow on equity offering to support funding for its flagship asset. These steps come as Lithium Americas, trading as TSX:LAC, continues to advance one of the largest known lithium resources in the United States. Lithium Americas enters this news cycle with its shares at CA$5.53 and...

If you are wondering whether Ultragenyx Pharmaceutical's current share price reflects its true worth, the recent valuation checks offer some useful clues for your own research. The stock last closed at US$20.42, with returns of a 5.9% decline over 7 days, 1.2% over 30 days, a 13.5% decline year to date, and a 47.5% decline over the past year, which may change how you think about its risk and return profile. Ultragenyx has been in focus as investors reassess higher risk biotech names, and...

Titan America (NYSE:TTAM) has agreed to acquire Keystone Cement, expanding its presence and capacity in the Mid-Atlantic region. The company reports record revenue, EBITDA and operating cash flows for 2025, despite sector headwinds. These developments have not yet been widely discussed and may reshape Titan America's growth profile and operational footprint. For investors tracking NYSE:TTAM, the stock last closed at $14.71, with a 1 year return of 15.1% and a 12.0% decline year to date...

OMV Petrom has received the first electrolyser for its 20MW green hydrogen e-fuel project at the Petrobrazi refinery, marking a key step in its hydrogen rollout. The company is also in early discussions with Ukraine's Naftogaz about a potential Black Sea offshore gas partnership, opening the door to new regional resource projects. For investors tracking WBAG:OMV, these developments come with the share price at €58.55 and a 21.3% return year to date, alongside a 42.5% return over the past...

Callaway Golf stock in focus after name change Callaway Golf (CALY) is back in the spotlight after reverting to its historic name in January 2026, following a period as Topgolf Callaway Brands Corp. The move is drawing fresh attention to its core golf equipment and apparel business. See our latest analysis for Callaway Golf. The recent name change headlines arrive as momentum rebuilds, with a 16.9% year to date share price return and a 107.3% 1 year total shareholder return contrasting with...

Wondering if Colgate-Palmolive at around US$85.50 is offering fair value, or if you might be paying up for a quality brand name. The stock is up 10.1% year to date, even after a 2.8% slip over the last week and a 10.6% pullback over the past month. The 1-year return sits at a 3.0% decline and the 3- and 5-year returns are 27.8% and 23.6% respectively. These mixed returns often prompt investors to reassess what they are really paying for, especially when a consumer staple name like...

Why Protalix BioTherapeutics is Back on Investors’ Radar Protalix BioTherapeutics (PLX) has drawn fresh attention after the European Commission approved a new Elfabrio dosing regimen for certain Fabry disease patients, alongside updated 2026 revenue guidance that includes a US$25 million regulatory milestone. See our latest analysis for Protalix BioTherapeutics. The Elfabrio dosing news and 2026 guidance update arrive after a mixed share price pattern, with a 28.9% 90 day share price return...

Royal Caribbean Cruises (NYSE:RCL) has announced Royal Beach Club Lelepa, the first exclusive Royal Beach Club destination in the Southern Hemisphere. The company plans an expanded 2027 to 2028 cruise lineup across Australia, the South Pacific, New Zealand, and Asia. The program includes the return of key ships to Asia and Australia, with new itineraries aimed at attracting both new and repeat guests. Royal Caribbean Cruises, trading around $272.0, has seen a 3 year return of about 7x and a...

Recent commentary around Lam Research (LRCX) centers on its role in supplying equipment for AI focused data centers, with demand tied to DRAM, NAND, foundry spending, and process steps such as 3D DRAM and advanced packaging. See our latest analysis for Lam Research. At a share price of US$233.99, Lam Research has recently seen strong short term momentum, with a 4.13% 1 day share price return and 35.83% 90 day share price return. The 1 year total shareholder return of 203.94% and 5 year total...

Rare disease growth and Alimera deal draw fresh attention to ANI Pharmaceuticals ANI Pharmaceuticals (ANIP) is back on investor radar after strong growth in its rare disease business, led by Cortrophin Gel, and the completed acquisition of Alimera Sciences, which expanded the company’s ophthalmology product portfolio. See our latest analysis for ANI Pharmaceuticals. The recent attention around Cortrophin Gel and the Alimera deal comes as ANI’s share price, now at US$74.82, shows softer short...

What recent performance says about Nihon Kohden (TSE:6849) Nihon Kohden (TSE:6849) has been under pressure, with the share price showing a 2.6% decline over the past day and negative returns over the past week, month, and past 3 months. Over longer horizons the pattern remains weak, with the 1 year total return at a 28.4% decline, around an 11.1% decline over 3 years, while the 5 year total return is slightly positive. See our latest analysis for Nihon Kohden. The recent 1 month share price...

American Express has removed Diversity, Equity, and Inclusion criteria from its board selection process following investor pressure. The change reflects growing debate in the U.S. over corporate DEI, ESG priorities, and shareholder rights. Both conservative and liberal investor groups have raised concerns about SEC actions that may affect proxy voting and disclosures. For investors watching NYSE:AXP, this governance shift comes as the share price stands at $294.93 and the stock has returned...

Eni (BIT:ENI) has reported full year 2025 results with fourth quarter revenue of €21.0b and basic EPS of €0.03, alongside net income of €90m. On a trailing twelve month basis EPS came in at €0.86 and net income at €2.6b. Over recent periods the group has seen revenue range between €20.5b in the third quarter of 2025 and €22.9b in the first quarter, with quarterly EPS moving from €0.17 to €0.38 as earnings growth of 4.7% over the past year met relatively modest revenue forecasts of 2.1% per...

General Dynamics recently declared a regular quarterly dividend of US$1.59 per share, payable on May 8, 2026, to shareholders of record on April 10, 2026, following a past fourth-quarter report that showed revenue and earnings growth across all four segments and a very large increase in backlog. This combination of higher cash returns to shareholders and broad-based operational momentum highlights how General Dynamics is balancing near-term income with longer-term contract-driven...

What triggered the latest interest in Evolution Mining? Recent analyst upgrades have put Evolution Mining (ASX:EVN) back on many investors’ radars, with JPMorgan and RBC Capital both pointing to operational performance, cash flow and a supportive backdrop for gold. See our latest analysis for Evolution Mining. Evolution Mining’s share price has pulled back recently, with a 15% 1 month share price return and a 2% year to date share price return. However, the 1 year total shareholder return of...

Robinhood Markets (NasdaqGS:HOOD) has launched a limited-invite Social feature focused on community, strategy sharing, and social trading. The company has also brought Robinhood Ventures Fund I into public view, with disclosed positions in private companies such as Stripe and ElevenLabs. These updates follow earlier product news on credit cards, banking tools, and tokenized assets, and point to a broader expansion of Robinhood's business model. For readers watching NasdaqGS:HOOD, these...

Wondering whether Xcel Energy's current share price reflects its true worth, or if the recent performance is masking a better or worse deal than it looks on the surface? The stock last closed at US$79.53, with returns of 6.5% year to date and 18.7% over the past year. This puts recent price moves firmly on investors' radar. Recent coverage has focused on Xcel Energy's role as a regulated utility and ongoing grid and infrastructure spending. This helps frame how investors view its long term...

Buyback announcement sets the stage Kimbell Royalty Partners (KRP) has authorized a share repurchase program of up to US$100 million, funded by cash on hand, free cash flow, or its revolving credit facility through December 31, 2027. See our latest analysis for Kimbell Royalty Partners. At a share price of US$14.51, Kimbell Royalty Partners has posted a 27.73% 90 day share price return and a 154.70% five year total shareholder return, with the recent buyback announcement and stronger Q4 2025...

American Eagle Outfitters (AEO) has just been upgraded to a top analyst ranking, with earnings projections and sentiment turning more positive. This places its earnings outlook and recent stock performance under closer investor scrutiny. See our latest analysis for American Eagle Outfitters. The recent upgrade and brighter earnings outlook come after a sharp shift in momentum, with a 1-day share price return of 1.45% contrasting with a 30-day share price return of 29.8% and a 90-day share...